tirzepatide discontinuation Comparison of versus placebo for safety outcomes: (1) When should tirzepatide (Mounjaro) be

P., Pasqualotto, E

Sesame Care Reviews: GLP-1 & Weight Loss Unlike many of the other GLP-1 telehealth platforms where you would simply be randomly matched with a healthcare provider

An engineered human albumin enhances half-life and transmucosal delivery when fused to protein-based biologics

In a double-blind crossover trial, patients with confirmed fructose malabsorption who took XI with a fructose load had lower hydrogen breath levels and fewer GI symptoms than on placebo, suggesting it may help those who experience discomfort from consuming apples, pears, honey, or high-fructose sweeteners.4 People taking GLP-1 medications (Ozempic, Wegovy, Mounjaro, etc.) GLP-1 receptor agonists commonly slow stomach emptying and cause nausea, fullness, and constipation

Retatrutide needs additional TRIUMPH trial results throughout 2026 before submitting for FDA approval in late 2026 or early 2027, with approval expected in late 2027 and launch in early 2028

This avoids adding bulk to a stomach that is already emptying slowly, which is a primary contributor to the bloating sensation GLP-1 users experience